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AND ACRONYM S
CHD = coronary heart disease
CI = conﬁdence interval
CVD = cardiovascular disease
GI = glycemic index
GL = glycemic load
HDL-C = high-density
lipoprotein cholesterol
HIC = high-income countries
LDL-C = low-density
lipoprotein cholesterol
LMIC = low- and middle-
income countries
MI = myocardial infarction
OR = odds ratio
RCT = randomized controlled
trial
RR = relative risk
SSB = sugar-sweetened
beverage
T2DM = type 2 diabetes
mellitusT here is much controversy surrounding theoptimal diet for cardiovascular health. Datarelating diet to cardiovascular diseases
(CVDs) has predominantly been generated from
high-income countries (HIC), but >80% of CVD
deaths occur in low- and middle-income countries
(LMIC). Relatively sparse data on diet and CVD exist
from these countries though new data sources are
rapidly emerging (1,2). Noncommunicable diseases
are forecasted to increase substantially in LMIC
because of lifestyle transitions associated with in-
creasing urbanization, economic development, and
globalization. The Global Burden of Disease study
cites diet as a major factor behind the rise in hyper-
tension, diabetes, obesity, and other CVD compo-
nents (3). There are an estimated >500 million
obese (4,5) and close to 2 billion overweight or obese
individuals worldwide (6). Furthermore, unhealthy
dietary patterns have negative environmental im-
pacts, notably on climate change.
Poor quality diets are high in reﬁned grains and
added sugars, salt, unhealthy fats, and animal-source
foods; and low in whole grains, fruits, vegetables,
legumes, ﬁsh, and nuts. They are often high in pro-
cessed food products—typically packaged and often
ready to consume—and light onwhole foods and freshly
prepared dishes. These unhealthy diets are facilitated
by modern food environments, a problem that is
likely to become more widespread as food environ-
ments in LMIC shift to resemble those of HIC (5,7,8).
In this paper, we summarize the evidence relating
food to CVD, and the powerful forces that underpin
the creation of modern food environments—what we
call the global food system—to emphasize the impor-
tance of identifying systemic solutions to diet-related
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(9–11). Although the “food system” may seem
remote to a clinician sitting in an ofﬁce seeing
a patient, its impact on the individuals they
are trying to treat are very real. This paper is on
the basis of a World Heart Federation inter-
national workshop to review the state of
knowledge on this topic. This review of diet,
dietary patterns, and CVD is not on the basis of
new systematic reviews or meta-analyses but
represents a careful review of many published
meta-analyses, seminal primary studies, and
recent research by the scholars who partici-
pated in the Consensus conference.
This paper presents: 1) an overview of the
development of the modern, globalized food
system and its implications for the food
supply; 2) a consensus on the evidence
relating various macronutrients and foods to
CVD and its related comorbidities; and 3) an
outline of how changes to the global food
system can address current diet-related pub-
lic health problems, and simultaneously have bene-
ﬁcial impacts on climate change.
THE CHANGING FOOD SYSTEM AND
FOOD SUPPLY AND IMPLICATIONS FOR
DIETS AND THE ENVIRONMENT
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FIGURE 1 Food System Impact on Nutrition-Related NCDs
Food
system
drivers
Food
system
Intermediate
factor
Nutrition
consumption
factors
Nutrition
outcomes
Health
outcomes
Public sector
institutions Retailers
Price and
availability Quantity
Balanced
diet Wellness
Agriculture
sector
development
Packaged
food sector Diversity
Under/over
nutrition
NCD
vulnerability
Climate
change/
Biodiversity loss
Agrochemical-seeds/
Agro-processing
Street food/fast
food/restaurant
sector
Quality Nutrientdeficiencies
Ecosystem
health
Source: revised version of Nugent, 2011 ”Bringing Agriculture to the Table“ Chicago Council on Global Affairs. NCD ¼ noncommunicable disease.
Anand et al. J A C C V O L . 6 6 , N O . 1 4 , 2 0 1 5
Diet, Cardiovascular Disease, and the Food System O C T O B E R 6 , 2 0 1 5 : 1 5 9 0 – 6 1 4
1592food system is characterized by a global web of in-
teractions between multiple actors from farm to fork,
geared toward maximizing efﬁciency to reduce costs
and increase production (Figure 1). The major actors
who control this system have changed dramatically in
HIC and LMIC, as described subsequently (13).
The shift to a global food system started in the
United States and other high-income industrialized
countries, and was driven initially by government
investment and intervention in markets, infrastruc-
ture and research intended to raise farm-sector pro-
ductivity. Building on actions taken in the late 19th
century (14), policies on agricultural research and
supporting on-farm production introduced in the
period from 1930 to 1960 in the United States (14) and
Europe focused on few major crops, particularly
grains (e.g., wheat, corn, rice), oilseeds (e.g., soy-
beans), livestock (e.g., pigs, poultry, cattle), and
critical cash crops, especially sugar cane and other
sources of sugar (15–18). State intervention in most
LMIC took a different form, such as policies to sub-
sidize food, taxes on agricultural products, and sys-
tems to control the supply and marketing of key
commodities (19–22). The 1960s also saw the start of
signiﬁcant agricultural transformation in LMIC, with
the “Green Revolution,” which focused on increasing
productivity of corn, rice, and wheat.
These investments and changes in production
systems were designed to make calories from staples(e.g., wheat, corn, rice) cheaply available, in order to
simultaneously address hunger in LMIC and national
food insecurity in HIC (23). In addition to vastly
increasing the calorie supply, the ensuing produc-
tivity boom also provided the basis of cheap feed for
livestock and cheap inputs for processed foods, in
turn creating incentives for the growth of manufac-
turers of processed foods (24). This coincided with
huge technological innovations in food processing,
(24–28), the rise of mass marketing to persuade con-
sumers to eat more, supermarket retailing, and fast
food (29,30). As a result of these changes, the trans-
formation of raw commodities into food and the dis-
tribution of consumable food items beyond the farm
gate has become far more important (31). Today,
integration and control of our farm-to-fork food
supply by major agribusinesses, food manufacturers,
retailers, and food service companies is more the rule
than the exception (13). Meanwhile, production of
less processed foods such as coarse grains (e.g., mil-
let, sorghum), roots, tubers, and legumes has
declined (32,33) whereas animal source food produc-
tion has grown dramatically (34).
Figure 2 sets out the stages of change involved in
leading to this modern food system. This model has
spread unevenly to most LMIC (35–37). Many coun-
tries retain various forms of state intervention in
agriculture and food systems (18,38–41), but policies
to liberalize trade and private sector investment have
FIGURE 2 Stages of Global Agricultural System Development
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1593revolutionized the entire sector in many regions
(13,42). Retailing has been transformed in LMIC
through the growth of supermarkets (18,38–41).
Although this process originated with companies in
industrialized countries looking for growth in foreign
markets, companies based in LMIC are now also
investing back into HIC.
DIETARY IMPACTS. The way people eat has changed
greatly across the globe; moreover, the pace of change
in LMIC is quickening. Snacking and snack foods have
grown in frequency and number (43–48); eating fre-
quency has increased; away-from-home eating in res-
taurants, in fast food outlets, and from take-out meals
is increasing dramatically in LMIC; both at home and
away-from-home eating increasingly involves fried
and processed food (47,49); and the overall proportion
of highly processed food in diets has grown (50,51).
These changes in the global food system coupled
with these food behavior shifts have enabled some
critical changes to the global food supply, all with
dietary implications. First is the shift to reﬁnedcarbohydrates—reﬁned grains and added sugars.
Rapidly increasing production of starchy staples com-
bined with processing technologies mean that reﬁned
ﬂour is increasingly dominant in diets.White bread, for
example, once rarely consumed in Latin America,
became widespread after the introduction of high-
yield wheat varieties. In Asia, white rice became
dominant as a staple over legumes and coarse grains,
with a more recent trend being rapidly rising con-
sumption of instant noodles as a staple (52,53).
Since 1964, average total carbohydrate intake in
the United States has increased from about 375 g/day to
500 g/day (from 2 to 6 kg/year of ready-to-eat cereals),
but the percent of carbohydrate that is ﬁber has
not substantially changed over this time, reﬂecting
increased reﬁned carbohydrates and sugar-sweetened
beverages (SSBs) is high in HIC (54). In the period from
1985 to 2005 extensive added sugar intake occurred
across HIC (55) but more recently large increases
have occurred in LMIC, particularly in consumption
of SSBs and processed foods (56–59). Today in the
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over 75% of foods, have some form of added sugar
(60). With urbanization there is some evidence to
show that reﬁned carbohydrate consumption is
increasing, whereas consumption of traditional
grains (i.e., millet, maize) is decreasing in LMIC
(61,62).
A second key change has been the increasing
intake of vegetable oils, including processed vege-
table oils, and a decline in consumption of animal fats
(2,63). This was initially driven by rising production
of soybeans in the United States, later in Argentina
and Brazil, and then palm oil in East Asia. Oilseeds are
now among the most widely traded crops, and are
also processed to create margarines and vegetable
shortenings and into partially hydrogenated fats and
bleached deodorized oils for use in processed foods
(Online Appendix, Box 2). Between 1958 and 1996, a
major global shift occurred in the amount and types
of available fats, with soybean, palm, and rapeseed/
canola oils replacing butter, tallow, and lard. From
1958 to 1962, soybean, palm, and rapeseed/canola oils
represented 20% of the 29 million metric tons of fat
produced globally per year, whereas butter, lard, and
tallow represented 37%. By 1996 to 2001, these oils
accounted for 52% of the 103 million metric tons of fat
produced globally per year, whereas butter, lard, and
tallow contributed 20% (64). This has implications for
consumption of fatty acids. Palm oil (deodorized) has
become an increasing source of saturated fatty acids;
and partially hydrogenated fats are the main source
of trans fatty acids. Between 1990 and 2010, global
saturated fat, dietary cholesterol, and trans fat in-
takes remained stable (trans fats going down in HIC
and up in LMIC), whereas n-6, seafood n-3, and plant
n-3 fat intakes each increased (65). Vegetable oil
consumption remains 2 times higher in HIC than in
LMIC. However, trans fat consumption is very high in
many LMIC although decreasing markedly in HIC. In
India, for example, vanaspati, a vegetable ghee used
in bakery products, fried snacks, and foods sold by
street vendors, is a leading source of trans fats, as is
bakery shortening. In 75 countries representing 61.8%
of the world’s adult population, global saturated fat
consumption was w9% of energy; though considerable
variation existed across countries (range 2% to 28%).
Country-speciﬁc omega 6 consumption ranged from
w1% to 13% (global mean: 6%) of energy; trans fat con-
sumption ranged fromw0.2% to 6.5% (global mean: 1%)
of energy; dietary cholesterol consumption ranged from
w97 to 440 mg (global mean: 228 mg) per day; seafood
n-3 ranged trans fat fromw35 to 3,886 mg (global mean:
163 mg) per day; and plant n-3 ranged from <w100 to
5,542 mg (global mean: 1,371 mg) per day (65).A third key change has been the increasing
global consumption of meat, which has been made
economically feasible by subsidized production of
crops for animal feed—most importantly corn and
soybeans (soybean oil is a byproduct of soymeal
production for animals) (66–69). At very low levels
of intake animal food consumption may not induce
harm, providing high-quality protein and iron,
whereas excess animal food intake in HIC may
be linked to adverse health outcomes, particularly
from processed meats (70). Meat consumption has
increased considerably worldwide, and there is sub-
stantially greater production of meat in HIC than in
LMIC (71). North and South America, Europe, and
Australia/New Zealand have the highest meat intake,
whereas Asia and Africa have the lowest (72,73).
Processed meats (which refers to post-butchering
modiﬁcations of foods such as curing, smoking, or
addition of sodium nitrate), account for 35.8% of all
meat consumed in HIC (unpublished data from the
PURE [Prospective Urban and Rural Epidemiological]
study) (71).
Dietary consumption patterns of other protein
sources have been mixed. Between 1973 and 1997,
dairy consumption per capita (kilograms) increased
in LMIC by w48% and is projected to almost double
(93% increase) by 2020. On average, ﬁsh consump-
tion is 2 to 3 times higher in HIC than LMIC (74),
although with marked heterogeneity within income
categories. China has the highest per-capita con-
sumption of ﬁsh in the world, followed by Oceania,
North America, and Europe (74). Globally, although
there has been little or no increase in sea ﬁsh con-
sumption per capita since the 1960s, catches per year
have risen exponentially (75) and freshwater ﬁsh
intake has increased during this time (71). Eggs are
similarly consumed in higher quantities (2 to 6 times
per week) in HIC relative to LMIC, with a 14% decline
in consumption in HIC observed between 1980 and
2000, and no change was observed in LMIC (76). The
consumption of legumes declined in the United
States from 1960 and into the 1980s, with reduced
consumption patterns observed globally (8). Rela-
tively, HIC such as Canada, the United States, and
Western Europe, tend to consume the lowest quan-
tities of legumes per capita in the world, whereas
LMIC within Africa and India consume the greatest
quantities of legumes, along with certain South
American countries where beef is uncommon, such
as Colombia and Peru (77–79). Globally, pulse con-
sumption has decreased since 1961, from w9.5 kg/
person/year in 1961 to 6.5 kg/person/year in 2006. In
LMIC countries pulses contributed w4% of energy to
the diets, and just 1% of energy to diets of HIC (80).
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1595Total production of tree nuts in 2012 was 3.5 million
metric tons, a 5.5% increase from 2011. World con-
sumption of tree nuts in 2011 exceeded 3 million
metric tons (81).
A fourth key change is the marked growth of pur-
chases of all packaged foods and beverages (all cate-
gories of processing). This process is accelerating
across all LMIC markets (13,82,83). For example,
58% of calories consumed by Mexicans come from
packaged foods and beverages, which is similar
throughout the Americas (83) and even within the
United States (66%) (65,84). The proportion for China
is 28.5% and rising rapidly (36,82,83). The component
of snack foods that is “ultra-processed” (i.e., ready to
eat) varies depending on the method of measurement
but is increasing wherever it is studied at all income
levels (50,85,86). The shift to ultra-processed foods
has not just affected the food available for consump-
tion but also the way food is consumed (87). The way
people eat has changed greatly across the globe and the
pace of change is quickening. Snacking and snack
foods have grown in frequency and number (43–48);
eating frequency has increased; away-from-home
eating in restaurants, in fast food outlets, and from
take-out meals is increasing dramatically in LMIC;
both at home and away-from-home eating increa-
singly involve fried and processed food (47); and
the overall proportion of highly processed food in diets
has grown (50,51).
A ﬁfth trend noted previously in relation to the
added sugar change is the shift in the way LMIC are
experiencing a marked increase in added sugar in
beverages. In the 1985 to 2005 period extensive added
sugar intake occurred across HIC (55) but more
recently large increases have occurred in LMIC,
particularly in consumption of SSBs and ultra-
processed foods (56–59). Today in the U.S. packaged
and processed food supply, >75% of foods have some
form of added sugar (60).
In addition, fruit and vegetable intake has re-
mained inadequate. Fruit and vegetable consumption
is substantially higher in HIC compared with LMIC
(88). Analysis of 52 LMIC countries taking part in the
World Health Survey (2002 to 2003) (89) found that
low fruit and vegetable consumption (i.e., <5 fruits
and vegetables per day) prevalence ranged from
36.6% (Ghana) to 99.2% (Pakistan) for men and from
38.0% (Ghana) to 99.3% (Pakistan) for women. Over-
all, 77.6% of men and 78.4% of women consumed less
than the minimum recommended 5 daily servings of
fruits and vegetables. In the United States, 32.6% of
adults consumed fruit 2 or more times per day and
27.2% ate vegetables 3 or more times per day (90). In
2012, 40.6% of Canadians 12 years of age and older,reported consuming fruits and vegetables 5 or more
times per day (91).
Although all of these changes across LMIC display
great heterogeneity (92), the global food system has
clearly reached all corners of the LMIC urban and
rural sector and major shifts in diets appear to be
accelerating.
IMPLICATIONS FOR ENVIRONMENTAL IMPACTS. The
modern food system is a major force in a range of
serious environmental problems, including climate
change (as a leading source of greenhouse gas emis-
sions, including carbon dioxide, methane, and nitrous
oxide), the loss of biodiversity, the strain on fresh-
water resources, and the release of persistent toxins,
excess nitrates and phosphates (from fertilizer and
concentrated livestock operations, causing wide-
spread problems of eutrophication), and animal phar-
maceutical residues into waterways (12,93–95).
The major causes are beef and other large animals
for greenhouse gas and the metabolic losses associ-
ated with shifting the product of nearly one-third of
the world’s arable land to concentrated animals,
which effectively magniﬁes the resource budgets and
pollution loads of industrial monocultures (34). The
expansion of low-input agriculture and extensive
ranching are also major factors in deforestation,
which bear heavily on both climate change (as carbon
is released from vegetation and soils and sequestra-
tion capacity diminishes) and biodiversity loss.
In addition to being a major force in many envi-
ronmental problems, world agriculture is also ex-
tremely vulnerable to climate change, biodiversity
loss, declining freshwater availability, and the inevi-
table limits of nonrenewable resources (e.g., fossil
energy, high-grade phosphorous) although vulnera-
bility is highly uneven on a world scale (96). Many of
the world’s poorest-regions are poised to be most
adversely affected by rising average temperatures,
aridity, and water stress, as well as through increas-
ingly severe extreme weather events such as drought
or ﬂooding; in fact some believe this is already
occurring (97–99).
It is also noteworthy that the Food and Agricul-
ture Organization of the United Nations estimates
that one-third of all food produced for human con-
sumption globally is wasted before it is consumed,
which has both social and environmental costs that
have been precisely measured in the United States
(100–102). Waste affects the entire food system from
production to post-harvest (including inside the
home) (102). Hall et al.’s (101) estimate of home food
waste of about 1,400 kcal/capita for the United
States adds up to 25% to 45% waste of total food for
some HIC.
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AND CVD RISK FACTORS
CARBOHYDRATES. Reﬁned carbohydrates. CVD Risk
Factors. U.S. ecological evidence demonstrates an
association of reﬁned carbohydrate (such as corn
syrup) with type 2 diabetes mellitus (T2DM) and
obesity (54). Robust data from systematic reviews and
high-quality randomized controlled trials (RCTs)
support a harmful effect of highly reﬁned, high–
glycemic load (GL) carbohydrates. A meta-analysis of
observational studies indicated that high–glycemic
index (GI) foods are associated with T2DM (103).
Proof-of-concept studies have used alpha-glucosidase
inhibitors, such as acarbose, to lower the GI of the
foods consumed; for example, in the STOP-NIDDM
(Study to Prevent Non-Insulin-Dependent Diabetes
Mellitus) trial, acarbose reduced progression to T2DM
by 25% compared with placebo (104). T2DM risk in
individuals with the highest GL and lowest cereal ﬁ-
ber is 2.5-fold that of those with the lowest GL and
highest cereal ﬁber diet (105). A large Danish pro-
spective cohort study of the impact of replacing
saturated fats with high-GI carbohydrates found that
when high-GI carbohydrates replace saturated fat,
myocardial infarction (MI) risk increases 33% (106).
A meta-analysis of 10 prospective cohort studies
(n ¼ 296,849) (107) found increased GL associated
with a 27% increased coronary heart disease (CHD)
and MI risk (108). In controlled-feeding studies,
replacing saturated fat with carbohydrates lowers
low-density lipoprotein cholesterol (LDL-C) and high-
density lipoprotein cholesterol (HDL-C) and increases
triglycerides (109). Dietary interventions that raise
HDL-C may not necessarily translate into CVD risk
reduction, as serum HDL-C has recently been called
into question regarding its role in the causal pathway
of CVD (110). However, in a 5-week controlled-feeding
trial of 163 generally healthy but overweight adults,
low compared with high-GI diets did not improve
insulin sensitivity, lipid levels, or systolic blood
pressure in the context of a healthy, DASH (Dietary
Approaches to Stop Hypertension)–like dietary
pattern, and a low compared with high-GI diet
increased LDL-C when the carbohydrate content of
the diet was high (109). This study suggests that the
adverse effect on CHD risk may not be mediated by
short-term effects on classical risk factors, but that
post-prandial hyperglycemia and hyperinsulinemia
or hyperlipidemia may play a mediating role; further
work is needed to clarify the effect of the GI on LDL-C
and related lipid risk factors.
LMIC. Highly reﬁned carbohydrates include polished
white rice, cornstarch, and white wheat ﬂour withreduced ﬁber content. Carbohydrate reﬁnement is
common in HIC and increasing in LMIC (111,112).
Traditional diets in LMIC, once rich in whole grains
and dietary ﬁber, now include highly reﬁned carbo-
hydrates, such as polished white rice and reﬁned
ﬂours. In East Asian countries, white rice consump-
tion is associated with a 55% higher T2DM risk
(111,112). In the cross-sectional CURES 57 (Chennai
Urban Rural Epidemiology Study 57) study, higher
reﬁned grain intake was associated with higher
waist circumference, systolic and diastolic blood
pressure, fasting glucose, triglycerides, and insulin
resistance and lower HDL-C levels (61). Replacing
white with brown rice (50 g/day) reduced T2DM risk
by 16% (113), and substituting beans for white rice
reduced the odds of metabolic syndrome by 35%
(108). However, a 16-week randomized trial of
replacing white with brown rice in middle-aged
Chinese men and women with or at high risk for
T2DM only improved HDL-C and reduced diastolic
blood pressure in the brown rice group. Data from
the international PURE study (138,926 individuals in
628 communities in 17 countries) suggest a need to
consider the context and availability of speciﬁc
foods before making food choice recommendations
(114). Increasing whole grain and cereal ﬁber
consumption whereas decreasing total and high-GI
carbohydrate are helpful strategies to prevent
T2DM and CVD in the general population (115).
Furthermore, low-GI diets improve glycemic control
and serum lipids in RCTs of participants with T2DM
with major implications for CHD risk reduction in
this vulnerable segment of the population whose
numbers are increasing rapidly globally (116–119).
Sugar-sweetened beverages. SSB and Cardiovascular
Risk Factors. SSB consumption accounts for up to
50% of added sugar in the American diet (120,121).
The epidemiological relationships between SSB con-
sumption, overweight, obesity, hypertension, and
T2DM are strong (122). In a meta-analysis of pro-
spective studies of SSB and hypertension, CHD, and
stroke, the relative risk (RR) for a 1-serving increase in
SSB/day was 1.17 (95% conﬁdence interval [CI]: 1.10 to
1.24) for CHD and 1.08 (95% CI: 1.04 to 1.12) for inci-
dent hypertension, but no clear effect was seen for
total stroke (RR: 1.06; 95% CI: 0.97 to 1.15) (123). A
meta-analysis of 7 cohort studies and 5 RCTs found
SSBs increased weight by 0.12 kg/serving/year (95%
CI: 0.10 to 0.14) in adults (124). A World Health Or-
ganization systematic review reported similar posi-
tive associations (125). In a pooled analysis of NHS
(Nurses’ Health Study) and HPFS (Health Pro-
fessionals Follow-up Study) data, a 1 SSB serving/day
increment is associated with a 1 kg weight gain over a
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compensation for this energy at other meals. After
adjusting for important potential confounders,
including body mass index, $1/day versus <1 SSB/
month increased T2DM by 39% (127). A meta-analysis
of 310,819 participants and 15,043 cases of T2DM re-
ported a 26% increased T2DM risk among those
consuming 1 to 2 SSB servings/day compared with
nonconsumers (128). A meta-analysis of 4 cohort
studies reported a linear association between SSB and
hypertension risk (RR) of 1.08 (95% CI: 1.04 to 1.12)
per serving per day (129). The Framingham Offspring
Study reported a 22% higher incidence of hyper-
tension among those consuming $1 SSB serving/day
compared with nonconsumers (130). A potential
explanation of the SSB-T2DM association is the high
content of rapidly absorbed sugar from corn syrup,
which increases blood glucose and insulin and de
novo lipogenesis—which may contribute to pancre-
atic beta cell dysfunction and eventually T2DM (131).
In the NHANES III (National Health and Nutrition
Examination Survey III) study, with 831 CVD deaths
during 163,039 person-years of follow-up, con-
sumption of $7 SSB servings/week was associated
with a 29% increased CVD mortality risk compared
with <1 serving/week (120), with no increased risk
up to 6 drinks/week. Few studies have investigated
the association between SSBs and CVD events.
Those that have, report increased CHD and stroke
risk with SSB consumption. A 2015 meta-analysis
reported an RR for incident CHD of 1.17 (95% CI:
1.10 to 1.24) per serving per day increase in
SSB consumption (129). Both the HPFS and the
NHS ﬁnd an approximate 20% increased CHD risk
in the highest category of SSB consumption com-
pared with the lowest category (132,133); and, after
adjusting for dietary and nondietary cardiovascular
risk factors, a 16% increased stroke risk (134). Simi-
larly, 2 Swedish prospective cohort studies in
women and men reported a RR of 1.19 (95% CI: 1.04
to 1.36) for stroke among those consuming $2 SSB
servings/day (135).
LMIC. Facing health concerns, the beverage industry
is shifting from full-calorie carbonated soft drinks to
lower-calorie carbonated soft drinks, coffees, and
teas. According to the NHANES study, between 1999
and 2006 the average U.S. full-calorie carbonated
soft drink intake decreased, whereas intake of diet
carbonated soft drinks, low-calorie fruit drinks, and
other sweetened beverages increased (122). These
products will gradually enter the markets in China,
Brazil, and other LMIC. However, there are
practically no data on the effects of SSBs on health
outcomes from LMIC (136,137).FATS AND OILS. CVD r isk factors . Vegetable oils
that are primarily comprised of mono- (e.g., olive oil)
and polyunsaturated fatty acids appear to reduce
CHD risk, and sources of the n-3 polyunsaturated fat
alpha-linolenic acid, such as rapeseed or canola oil,
are cardioprotective. Replacing saturated fat with
monounsaturated or polyunsaturated fat reduces
LDL-C and preserves HDL-C (109). Further, canola oil,
as part of a low-GI diet, improves glycemic control
and blood lipids in T2DM (138). Trans fatty acids in-
crease CHD risk compared with other macronutrients,
with strong evidence of adverse effects of small
amounts of trans fats on lipids (109,139) and CVD risk
(140,141).
Though total fat (142), and speciﬁcally saturated
fats, have generally been considered to be deleterious
to insulin sensitivity (143), in large cohort studies,
saturated fat is not associated with development of
T2DM, after adjustment for body mass index, total di-
etary ﬁber, or magnesium intake (144–149). Macronu-
trient exchange generally does not inﬂuence markers
of glucose homeostasis, though in 2 relatively large
trials, replacing saturated fat with either mono-
unsaturated fat or carbohydrate improved indices of
glucose homeostasis (150,151). Associations have been
seen betweenmajor food sources of saturated fat, such
as red and processed meat, and development of T2DM
(152,153), though dairy products, notably fermented
dairy, may be protective (154,155).
CVD. Saturated fats have not been consistently
associated with CVD in meta-analyses of cohort
studies (odds ratio [OR]: 1.07; 95% CI: 0.96 to 1.19)
of higher compared with lower intakes (156). How-
ever, in most of these studies the association of
high saturated fat intake largely represents repla-
cing highly reﬁned carbohydrates. Replacing satu-
rated fat with highly reﬁned carbohydrate is not
associated with lower CHD risk, whereas replacing
saturated fat with polyunsaturated fat reduces CHD
risk (157,158). This beneﬁt of polyunsaturated fat
includes the primary n-6 polyunsaturated fatty acid,
linoleic acid (158,159). Replacing saturated fat with
high-GI carbohydrate increases MI risk by 33%,
whereas replacing with low- and medium-GI carbo-
hydrates appears neutral (106). Emerging evidence
suggests that the effect of a saturated fat on CHD
may depend on the type of fatty acid and the spe-
ciﬁc food source (i.e., dairy vs. meat) (160,161).
Consumption of nonhydrogenated vegetable oils
appears to be superior to consumption of animal
fats (162). Consumption of plant oils in a Mediter-
ranean diet reduced CVD in 2 RCTs. The Lyon
Diet Heart Study found regular consumption of
alpha-linolenic acid (canola oil) signiﬁcantly reduced
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PREDIMED (Prevención con Dieta Mediterránea) RCT
found that a Mediterranean diet (50 g/day extra virgin
olive oil) reduced CVD events by 30% over a 5-year
period (164).
Palm oil is the dominant fat globally and is rela-
tively high in saturated fat. On the basis of controlled-
feeding studies examining changes in blood lipids,
replacing palm oil with unsaturated fatty acids would
be expected to lower CHD risk (109), but palm oil
would be preferred to partially hydrogenated oils
high in trans fatty acids. Few studies have directly
compared palm oil with other oils for CHD risk. One
large case-control study in Costa Rica found that
soybean oil consumption was associated with lower
acute MI risk compared with palm oil consumption
(165).
Summary of fats and o i l s . Compared with satu-
rated fat, vegetable oils rich in polyunsaturated fats
reduce the TC:HDL-C (total cholesterol:HDL-C) ratio
and CHD incidence; inclusion of n-3 fatty acids
(alpha-linolenic acid) with the vegetable oils is
important for CHD prevention. The effect of
replacing saturated fat with carbohydrate on CHD
risk appears to depend on the quality of the carbo-
hydrate. Prospective studies consistently indicate
adverse effects of trans fats on CHD. Effects of
monounsaturated fat from plant sources require
further study; extra virgin olive oil appears to re-
duce CVD.
PROTEIN SOURCES. Meats . Nutrients and CVD Risk
Factors.Meat is rich in protein, iron, zinc, and B
vitamins, but can also contain signiﬁcant amounts
of cholesterol and saturated fatty acids, which
raise LDL-C and lower triglyceride (157). A high
red meat intake (rich in heme iron), increases
endogenous formation of N-nitroso compounds in
the gastrointestinal tract that are associated with
increased epithelial proliferation, oxidative stress,
and iron-induced hypoxia signaling (166–168).
In a meta-analysis of 17 cohort studies (16 from
Western countries), consumption of red and pro-
cessed meat increased T2DM and CHD risk, but few
included studies examined unprocessed red meat
(169). Intake of red or processed meat was not asso-
ciated with stroke, but only 3 studies evaluated these
relationships (169). In more recent analyses, red
meats, particularly processed red meats, were asso-
ciated with increased CVD, CHD, stroke, and cancer
mortality, whereas poultry was not (170–172). Poten-
tial mechanisms linking unprocessed red meat with
CVD include saturated fat, cholesterol, iron, phos-
phatidylcholine, and carnitine; and cooking methods
(e.g., barbecuing), that increase heterocyclic aminecontent and N-nitroso compounds, also implicated in
colorectal cancer (167). The evidence suggests that
processed meat consumption increases CHD risk,
whereas unprocessed meat consumption has a small
or no association with CHD, mainly when compared
with reﬁned starch and sugar. Both unprocessed and
processed red meats are associated with greater CVD
risk compared with poultry, ﬁsh, or vegetable protein
sources. Both types of meat are associated with
higher T2DM risk, although gram for gram the effect
size is notably larger for processed meats.
LMIC. Data relating meat consumption to CVD risk in
LMIC is limited. A recent pooled analysis of data
from 296,721 individuals from Asian countries (i.e.,
Bangladesh, mainland China, Japan, Korea, and
Taiwan) found no association between red meat and
poultry consumption and CVD, cancer mortality, or
all-cause mortality (173). Red meat intake is generally
much lower in these areas than in HIC however, and
current consumption does not likely reﬂect long-
term patterns.
Dairy . CVD Risk Factors. The consumption of dairy
products has been associated with weight loss in
small studies (174), but the overall published data
does not conﬁrm an important effect on body weight.
However, increased low-fat dairy consumption is
associated with lower LDL-C, triglycerides, plasma
insulin, insulin resistance, waist circumference, body
mass index, possibly blood pressure; and reduced
diabetes risk (174–182). In a large meta-analysis of
cohort studies (13,000 incident cases), and the EPIC
InterAct (European Prospective Investigation into
Cancer and Nutrition) case-cohort study (12,000
incident cases), fermented dairy (i.e., yogurt,
cheese, and thick fermented milk), but not total
dairy, was inversely associated with T2DM (155,183).
In a meta-analysis of prospective cohort studies,
milk consumption was inversely associated with
total CVD in a small subset of studies with few
cases, but using a larger body of data with more
speciﬁc endpoints, milk was not associated with
CHD or stroke (173). In a prospective cohort study
of 53,387 Japanese men and women, higher dairy
calcium (173 mg/day vs. none) reduced risk for
hemorrhagic stroke, ischemic stroke, and stroke
mortality by w50% over a 10-year follow-up (184).
Collectively, these studies do not suggest a strong
or consistent relationship between consumption of
dairy products and T2DM and CVD risk.
LMIC. Data on dairy consumption and CVD in LMIC
are limited. In a prospective cohort of 2,091 middle-
aged Chinese men and women monitored for 6
years, individuals who reported consuming >1
dairy serving/day were 35% less likely to develop
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nonconsumers (185).
Egg. CVD Risk Factors. Eggs are a relatively in-
expensive and low-calorie source of protein, folate,
and B vitamins (186). Eggs are also a source of
dietary cholesterol (a medium egg contains approxi-
mately 225 mg of cholesterol) (187). A meta-analysis
showed that eggs increase TC, HDL-C, and TC:HDL-C
(188), but 5 RCTs subsequently reported that egg
consumption did not signiﬁcantly alter these para-
meters (189–191) or endothelial function (192,193). No
RCT has tested the effect of egg consumption on CVD
events. In a meta-analysis (194) of 16 prospective cohort
studies (90,735 participants) (191), egg consumption
was not associated with overall CVD or CHD, stroke, or
CHD or stroke mortality; but was associated with T2DM.
Overall, consumption of eggs in moderation (1 egg/day)
is likely neutral for CVD. However, relative to other
protein-rich foods that lower LDL cholesterol, such as
whole grains and nuts, eggs would likely increase
CVD risk.
LMIC. Unpublished data from 3 large international
studies, PURE (Prospective Urban and Rural Epide-
miological Study), ONTARGET (Ongoing Telmisartan
Alone and in Combination with Ramipril Global
Endpoint Trial), and INTERHEART (a global study of
risk factors for acute myocardial infarction), with
collectively 200,000 individuals and 22,000 CVD
events from regions including China, India, and Af-
rica, show that moderate egg consumption appears to
be neutral or protective against CVD. However, sig-
niﬁcant variations exist across regions, with a beneﬁt
of daily egg consumption in China but possible harm
in South Asia.
F ish . CVD Risk Factors. Fish are a source of protein,
vitamin D, multiple B vitamins, essential amino
acids, and trace elements; and the long-chain
omega-3 (n-3) fatty acids docosahexaenoic acid and
eicosapentaenoic acid (195,196), though amounts
vary over 10-fold across seafood species. Fatty
ﬁsh, such as salmon, sardines, trout, white tuna,
anchovies, and herring, have the highest con-
centrations. In clinical trials and meta-analyses of
these trials the long-chain omega-3 polyunsaturated
fatty acids in ﬁsh reduced multiple CVD risk factors,
including vascular resistance, blood pressure,
inﬂammation, serum lipids, and endothelial function
(197).
Some prospective cohort studies ﬁnd an inverse
association between ﬁsh intake and CVD mortality,
whereas others do not (198). Available evidence
suggests cardiovascular beneﬁts with ﬁsh consump-
tion in secondary prevention, but the evidence is
inconsistent regarding primary prevention. Possibleexplanations include differences in the amounts and
types of ﬁsh consumed, cooking methods, and
background ﬁsh consumption. Fifteen of the 16
cohort studies (with 1 exception) (199) were con-
ducted in North America and European countries,
where deep-frying ﬁsh is common. The DART-1 (Diet
and Reinfarction) trials, a secondary prevention trial
and DART-2, in men with stable angina, are the only
randomized trial of ﬁsh intake and CVD outcomes.
They arrive at opposite conclusions. In the DART-1
trial, ﬁsh lowered all-cause mortality and trended
toward reducing CVD events after 2 years (194). In
the DART-2 trial oily ﬁsh did not affect all-cause
mortality or CVD events after 3 to 9 years, and
increased sudden cardiac death, largely conﬁned to
the subgroup given ﬁsh oil capsules (200). Differ-
ential behavioral change or CVD stage may explain
the discrepancy (201). Follow-up of the DART-1 trial
at 5 years also showed increased rates of CVD in the
ﬁsh/ﬁsh oil group that did not persist through the
10-year assessment (202). We know of no primary
prevention trial on ﬁsh intake and CVD outcomes,
but a meta-analysis of ﬁsh oil supplement RCTs is
neutral (203).
Low-Income Countries and HIC.Most of the data indi-
cating that ﬁsh is protective comes from studies
in HIC (204–208). Unpublished data from 3 large
international studies (PURE, ONTARGET, and
INTERHEART) reﬂect considerable heterogeneity in
the association between ﬁsh intake and CVD out-
comes. In the PURE study ﬁsh intake was inversely
associated with CVD outcomes in South America,
China, North America, and Europe (RR: 0.76 to
0.84) but positively associated in South Asia (RR:
1.97). However, no associations between ﬁsh con-
sumption and CVD outcomes were observed in a
high-risk secondary population in the ONTARGET
study. The INTERHEART study found ﬁsh intake
beneﬁcial in North America and Europe (RR: 0.73;
95% CI: 0.62 to 0.87) but harmful in the Middle
East (RR: 1.59; 95% CI: 1.32 to 1.93). More work is
needed in China and India to understand the
effects of regional types and preparation methods
of ﬁsh.
Nuts . CVD Risk Factors. In clinical trials nuts improve
serum lipids (209–211). In observational studies, nuts
lower CHD (196,212,213) and hypertension risk (213);
but not stroke (207,213). In 1 meta-analysis of pro-
spective cohorts, nuts were not associated with T2DM
(214), but in another, they were protective (207).
Despite their high energy density, nuts do not
contribute to weight gain, changes in waist circum-
ference, or obesity, perhaps due to their satiating ef-
fects and increased fecal energy losses (215,216).
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1600In observational studies (133,217–220) and RCTs
(164,221–223), a Mediterranean diet including nuts
lowers CVD risk. However, no RCTs have assessed the
effects of nut consumption alone on CVD events.
Taken together, the published data from observa-
tional studies and clinical trials support nuts for
lowering CVD risk.
LMIC. Unpublished data from the PURE cohort
indicate that nut consumption is very low in LMIC
(60% of individuals consume #1 nut serving/week).
No associations between nut consumption and
CVD outcomes are seen at this low level.
Legumes . CVD Risk Factors. In observational studies
and RCTs consumption of legumes improves CVD risk
factors, such as waist circumference, cholesterol,
blood pressure, C-reactive protein, glucose; and is
protective against T2DM (224–231). A meta-analysis of
26 RCTs (1,037 participants) found that 130 g legumes/
day (w1 serving) reduced LDL-C by 0.17 mmol/l (95%
CI: –0.25 to –0.09) (228). Legumes also reduce systolic
blood pressure (by 2 mm Hg) and lowered mean
arterial pressure (231) in a meta-analysis of 8 RCTs.
A legume-rich diet reduced HbA1c (–0.3%; 95% CI:
–1.4% to –0.1%) in an RCT in participants with
diabetes (226).
CVD. In a meta-analysis of 5 observational studies,
100 g of legumes 4 times/week is inversely
associated with CHD (RR: 0.86; 95% CI: 0.78 to 0.94)
(232). However, that study and another meta-
analysis of 8 prospective cohort studies found no
association between legumes and diabetes (207) or
stroke (232,233). A large prospective study of 2
cohorts of U.S. health professionals found a 45%
increased risk of ischemic stroke per daily serving of
legumes (RR: 1.45; 95% CI: 1.06 to 2.00) (234). This
suggests that although legumes are valuable to
reduce CHD risk, more research is required to
understand their impact on total stroke risk.
LMIC. In a cohort of Chinese men and women, soy
(the primary legume consumed in China) was
negatively correlated with TC and LDL-C (235). A
population-based cross-sectional study in India
found that women consuming legumes once/day
were less likely to develop T2DM (OR: 0.55; 95%
CI: 0.34 to 0.88; n ¼ 99,574). A similar but
nonsigniﬁcant trend was observed in men (OR: 0.70;
95% CI: 0.39 to 1.26; n ¼ 56,742) (236). In a
prospective cohort study of middle-aged Shanghai
women, a w50 g/day increase in legume con-
sumption over 4.6 years reduced T2DM risk by 38%
(RR: 0.62; 95% CI: 0.51 to 0.74) (237). A prospective
cohort study of 64,915 Chinese women 40 to 70
years of age (n ¼ 62 cases; follow-up 2 years) found
that individuals consuming $11.2 g/day of soyprotein were less likely to develop CHD (RR:
0.25; 95% CI: 0.10 to 0.63) than were those
consuming #4.5 g/day (238).
Summary of major prote in sources . Reducing red
meats, especially processed meats, and increasing
ﬁsh, nuts, legumes, and possibly fermented dairy
products are likely beneﬁcial. Sustainability issues
discussed in this paper must also be addressed spe-
ciﬁcally in relation to meat, ﬁsh, and dairy foods
(12,34,239–241).
FRUITS AND VEGETABLES. CVD r isk factors . In the
DASH RCT, higher intake of fruits and vegetables,
either as part of a typical Western diet or the DASH
eating plan, reduced blood pressure, TC, LDL-C, and
HDL-C without affecting triglycerides (242). A meta-
analysis of 3 prospective cohorts (3,415 cases) found
high adherence to the DASH eating reduced T2DM
risk by 27% (243). A strong evidence base from
observational studies indicates that high consump-
tion of vegetables and fruits reduces CHD and
stroke (196).
CVD in HIC and LMIC . Large global studies and
systematic reviews of prospective cohorts generally
support a protective role of fruits and vegetables
against CVD (244–246). In the global INTERSTROKE
study (3,000 stroke cases and 3,000 control cases),
compared with fewer than 1 serving per day, 1
serving of fruit was protective against stroke (OR:
0.61; 95% CI: 0.50 to 0.73), but the beneﬁts were
not clear with higher consumption of up to 3 serv-
ings/day of vegetables was not (OR: 0.91; 95% CI:
0.75 to 1.10) (244). A meta-analysis of 20 prospec-
tive cohort studies (16,981 stroke events) found that
fruit and vegetable consumption was associated
with decreased stroke risk (RR: 0.79; 95% CI: 0.75 to
0.84 for highest vs. lowest categories), as were
fruits (RR: 0.77; 95% CI: 0.71 to 0.84) and vegeta-
bles (RR: 0.86; 95% CI: 0.79 to 0.93) separately
(245). In unpublished INTERHEART study data a
1-serving/day increase in fruit decreased MI risk by
12% (RR: 0.88; 95% CI: 0.84 to 0.92); a 1-serving/
day increase in vegetables decreased MI risk by 5%
(RR: 0.95; 95% CI: 0.92 to 0.97). Large meta-
analyses of observational studies support a w5%
to 10% reduction in CVD mortality per serving per
day (246), and a protective association of green
leafy vegetables with T2DM (RR per 0.2 servings/
day: 0.87; 95% CI: 0.81 to 0.93) (247). The beneﬁcial
effects of fruits and vegetables appear consistent
across regions of the world. A major issue has been
the lack of success in encouraging increased fruit
and vegetable consumption by the citizens of
western nations (248).
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and added sugar (i.e., carbohydrates of lower quality)
have paralleled the rise in obesity and T2DM. Collec-
tively, the data support emphasizing low-GI whole
grains, legumes, and nuts, fruits, and vegetables and
minimizing high-GI reﬁned grains and foods with
added sugars, including SSBs (Table 1).
DIETARY SODIUM. Sodium is an essential nutrient
required for normal physiological function (249–251).
Increasing sodium intake well beyond physiological
requirements increases blood pressure (241–243) and
CVD mortality (95–97). In LMIC sodium sources
include table salt and salt additives and spices;
whereas processed foods are the primary source in
HIC. Sodium consumption has declined slightly in
LMIC as refrigeration has replaced salted-preserved
foods. Short-term RCTs have reported reductions
in blood pressure with reduced sodium intake
to <1.5 g/day. Population recommendations for low
sodium intake (252–254) (<2.0 g/day) have been ach-
ieved in short-term feeding clinical trials (254), but not
sustained in longer-term clinical trials (>6 months)
(255–257). No RCTs have determined whether low so-
dium intake reduces CVD events or deaths compared
with moderate intake (249). Meta-analyses of CVD
event trials did not report a signiﬁcant reduction in
CVD with lower sodium intake, but the included trials
were underpowered to detect moderate risk re-
ductions (258). Prospective cohort studies suggest a
J-shaped association between sodium intake and CVD
events, consistent across methods of sodium estima-
tion (259–265). In a recent Cochrane Review (266) of 23
epidemiological studies (n ¼ 274,683), the lowest
risk of CVD events and deaths occurs at an intake be-
tween 2.7 and 5.0 g/day. PURE study ﬁndings (263)
are consistent with this evidence, with sodium
excretion both>6 g/day and<3 g/day being associated
with higher mortality and CVD events compared to
4.00 to 5.99 g/day, despite an overall positive associ-
ation between sodium excretion and blood pressure
(251,263). The increased risk of CVD events with higher
sodium intake (>5 g/day) was most prominent in those
with hypertension (263). However, methodological
issues make studies of sodium intake particularly
challenging (267). Additional large appropriately
designed observational studies and RCTs are needed
to provide further evidence on optimal sodium intake
for preventing CVD events (249,268–270).
ALCOHOL. Consumption patterns. Greater amounts of
alcohol are consumed per capita by adults in HIC (9.6
l/year) than in LMIC (4.1 l/year), or low-income
countries (3.1 l/year), although this may be an un-
derestimate in LMIC and low-income countries due tothe use of homemade or unsafe alcohol products
(e.g., industrial or medical) (271). In the PURE study,
31% of participants identiﬁed as current drinkers,
with considerable variation across income regions
(13% to 80%). In all regions, men were more likely to
be current drinkers than were women (272).
CVD r isk factors . In a meta-analysis of randomized
controlled intervention studies of 2 to 8 weeks’
duration (273), moderate alcohol consumption (up to
1 drink or 15 g/day in women; or up to 2 drinks or
30 g/day in men) compared with no alcohol: raised
HDL-C, Apo-A1, and adiponectin, and reduced LDL-C
and ﬁbrinogen. Total cholesterol, triglycerides, and
lipoprotein (a) were not signiﬁcantly affected. Results
stratiﬁed by beverage type (wine/beer/spirits) were
similar to the pooled analyses. The changes in lipid
and hemostatic risk factors align with lower cardio-
vascular risk.
CVD. The EPIC (European Prospective Investigation
on Cancer and Nutrition) study monitored 380,395
participants for 13 years (4,187 CVD deaths) (274).
Female never-drinkers were at increased risk of CVD
death (RR: 1.31; 95% CI: 1.13 to 1.53) compared with
moderate drinkers (0.1 to 4.9 g/day); but the associ-
ation was not signiﬁcant for male never-drinkers (RR:
1.20; 95% CI: 0.89 to 1.62). In a dose-response meta-
analysis of 24 prospective cohort studies (275), the
association of drinking with CHD was J-shaped:
nondrinkers were at slightly increased risk; in men
the greatest protection was at 31 g/day with a trend
for increased risk beginning at 63 g/day; for women,
the greatest protection was at 11 g/day with a trend
for increased risk beginning at 14 g/day. In a meta-
analysis of 27 prospective studies of alcohol and
stroke, no association was found between light or
moderate alcohol use and stroke, but heavy alcohol
use (>45 g/day) was shown to increase total stroke
risk (RR: 1.20; 95% CI: 1.01 to 1.43), particularly
hemorrhagic stroke (RR: 1.29 ; 95% CI: 0.98 to 1.71)
(275). Patterns of alcohol consumption may be a
particularly important determinant of the magnitude
of the association—in a meta-analysis of 10 prospec-
tive cohort and 4 case-control studies, irregular
“binge” drinking (>60 g of pure alcohol or $5 drinks
per occasion at least monthly) increased CHD risk by
45% (RR: 1.45; 95% CI: 1.24 to 1.70) (276). In summary,
small and inconsistent cardiovascular beneﬁt is seen
in moderate drinkers, but a strong increase in CVD
and stroke risk is seen with regular heavy alcohol
consumption and binge drinking.
LMIC . In HIC/upper middle income countries in the
PURE study (272), current drinking was protective
against MI, but not in low-income countries/LMIC
(p ¼ 0.02 for interaction); a similar trend was seen for
TABLE 1 Summary of Evidence of Associations Between Major Foods and Cardiovascular Disease
Food
HIC LMIC
SustainabilityDeﬁnitely Known Suggested Strength of Evidence Deﬁnitely Suggested Strength of Evidence
Reﬁned carbohydrates
(solid foods)
Reﬁned, high-glycemic
carbohydrates are
associated with T2DM
and CHD.
Reﬁned, high-glycemic
carbohydrates adversely affect
the lipid proﬁle.
High (SRMA of both RCT and
prospective cohorts).
None. Reﬁned, high–glycemic index
carbohydrates are
associated with T2DM,
markers of central
adiposity, blood pressure,
insulin, and lipids.
Moderate (cross-
sectional, RCT).
Moderate.
Sugar-sweetened
beverages
Excessive sugar-sweetened
beverage consumption
is associated with CVD
mortality, stroke, obesity,
hypertension, and T2DM.
None. High (SRMA of both RCT and
prospective cohorts).
None. None. Absent. Low.
Saturated fats None. Replacement of saturated fats
with unsaturated plant fats or
low-glycemic carbohydrates
reduces the risk of
cardiovascular disease, and
reduces LDL-C, without
adversely affecting HDL-C.
High (SRMA of both RCT and
prospective cohorts).
None. None. None. Low; higher saturated
fat from palm oil is
unsustainable.
Trans fatty acids Replacement of trans fatty
acids with unsaturated
plant fats or low-glycemic
carbohydrates reduces the
risk of CVD, and reduces
LDL-C, without adversely
affecting HDL-C.
None. High (SRMA of both RCT and
prospective cohorts).
None. None. None. Low.
Unsaturated fatty acids
(MUFA, PUFA)
Diets higher in unsaturated
plant fats
(monounsaturated and
polyunsaturated fats from
plants and ﬁsh) reduce risk
of CVD, and improve the
lipid proﬁle.
None. High (SRMA of both RCT and
prospective cohorts).
None. None. None. Low.
Red and processed
meat
Red and processed meats are
associated with CHD and
T2DM.
Red and processed meats are
associated with stroke.
Moderate (SRMA of
prospective cohorts).
None. No association between red
meat consumption and
CVD in LMIC.
Low (1 pooled analysis). Very high; meat
production is
harmful to the
environment.
Dairy None. Higher low-fat and fermented
dairy products are inversely
associated with CVD, blood
pressure, and improved serum
lipids.
Moderate (SRMA of both RCT
and prospective cohorts).
None. Consuming dairy is associated
with reduced risk of T2DM.
Low (single prospective
cohort).
Very high; cow’s milk
production is
harmful to the
environment and
resource-intensive.
Eggs None. Consuming <7 eggs per week does
not increase risk of CVD, nor do
they affect the lipid proﬁle.
Low (SRMA of prospective
cohorts, SRMA of RCTs on
lipids).
None. Moderate egg consumption
appears protective against
CVD.
Low (unpublished case-
control data from 3
large international
studies).
Moderate.
Continued on the next page
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TABLE 1 Continued
Food
HIC LMIC
SustainabilityDeﬁnitely Known Suggested Strength of Evidence Deﬁnitely Suggested Strength of Evidence
Fish None. Long chain omega-3 fats from ﬁsh
reduce multiple CVD risk
factors.
Low (SRMA of prospective
cohorts, large RCTs that
conﬂict).
None. There is considerable
heterogeneity in the
association between ﬁsh
and CVD outcomes.
Low (unpublished case-
control data from 3
large international
studies).
Sustainability of ﬁsh is
challenging.
Nuts Many varieties of nuts show
beneﬁcial effects on
LDL-C, the LDL-C:HDL-C
ratio, TC, and
triglycerides; and nuts
reduce CHD risk and
hypertension, but not
stroke.
Nuts may reduce risk of T2DM. High (SRMA of both RCT and
prospective cohorts).
None. Nuts are not associated with
CVD outcomes.
Weak (single
observational study).
Sustainable alternative
protein source to
meat.
Legumes Legumes show beneﬁcial
effects on LDL-C, the
LDL-C:HDL-C ratio, TC,
and triglycerides; and
legumes reduce CHD
risk and hypertension, but
not stroke.
Legumes reduce CHD risk,
but not stroke risk.
High (SRMA of both RCT and
prospective cohorts).
None. Legume consumption reduces
risk of CHD and T2DM.
Weak (small number of
prospective cohort
studies, cross-
sectional association).
Sustainable alternative
protein source to
meat.
Fruits and vegetables Diets high in fruits and
vegetables reduce blood
pressure, TC, LDL-C, and
HDL-C and protect against
CVD.
None. High (SRMA of both RCT and
prospective cohorts).
None. Protective role of fruits and
vegetables against CVD.
Weak (small number of
prospective studies).
Sustainable source of
carbohydrate
energy and
micronutrients.
Sodium None. Lower sodium diets reduce blood
pressure, but the association
between lower sodium and
CVD is unclear.
Low (conﬂicting observational
and RCT data).
None. Excessive or low-sodium diets
are associated with CVD.
Low (single multicountry
study).
Low.
Alcohol Compared with nonalcoholic
beverages, alcoholic
beverages raise HDL-C.
Compared with not drinking,
moderate drinking (up to 5 g
alcohol/day) may reduce risk
of CVD; but higher intakes
(>30 g/day and above)
increase risk of hemorrhagic
stroke and cancers.
Low (SRMA of both RCT and
prospective cohorts)
None. Alcohol does not reduce risk
of MI in LMIC.
Low (single multicountry
study).
Low.
DASH dietary pattern Following a DASH dietary
pattern lowers blood
pressure and serum lipid
risk factors for CVD.
Higher DASH diet scores are
associated with reduced all-
cause mortality, CVD, and
cancer mortality.
Moderate (RCT data,
prospective cohorts, but
no long-term event trials).
None. None. None. Low if only plant based;
moderate when
uses low-fat dairy
as key aspect.
Dietary portfolio Following the dietary
portfolio approach lowers
blood pressure and serum
lipid risk factors for CVD.
None. Moderate (strong RCT data,
but no event trials).
None. None. None. Focus on plant foods
enhances
sustainability.
Mediterranean diet Following a Mediterranean
diet is associated with
reduced CVD, blood
pressure, and serum lipid
risk factors for CVD.
None. High (SRMA of both RCT and
prospective cohorts).
None. None. None. Low.
CHD¼ coronary heart disease; CVD¼ cardiovascular disease; DASH¼ Dietary Approaches to Stop Hypertension; HDL-C ¼ high-density lipoprotein cholesterol; HIC ¼ high-income countries; MUFA¼mono-unsaturated fats; LDL-C¼ low-density lipoprotein cholesterol;
LMIC ¼ low- and middle-income countries; MI ¼ myocardial infarction; PUFA ¼ polyunsaturated fats; RCT ¼ randomized controlled trial; SRMA ¼ systematic review/meta-analysis; T2DM ¼ type 2 diabetes mellitus; TC ¼ total cholesterol.
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1604stroke, but the between-region difference was not
signiﬁcant (p ¼ 0.15 for interaction). In low-income
countries and LMIC, heavy episodic drinking pattern
and higher intakes of alcohol were associated with a
composite outcome of mortality, MI, stroke, cancer,
injury, and hospitalization. Current drinking was
associated with an increased risk of alcohol-related
cancers.
Summary of a lcohol . The CVD risk beneﬁts of
moderate alcohol consumption (up to 5 g/day)
compared with abstinence are small but consistent
within individual study populations. Higher levels of
consumption increase CVD risk, beginning at 30 g/day
in women and 45 g/day in men. Therefore, recom-
mendations for moderate alcohol consumption for
CVD prevention in people who already drink must
consider individual preferences, population-speciﬁc
responses, and risk of comorbid conditions, such as
addiction and cancers. It is not recommended that
nondrinkers take up drinking.
DIETARY PATTERNS. Dietary pattern analysis as-
sesses overall diet quality and is easier to translate
into dietary recommendations than recommendations
for single foods or nutrients (277). The U.S. Dietary
Guidelines Advisory Committee modeled 3 dietary
patterns—the Healthy U.S.-Type Pattern, the Healthy
Mediterranean-Style Pattern, and the Healthy Vege-
tarian Pattern—for healthfulness and nutritional ade-
quacy. All 3 include components of a dietary pattern
associated with health beneﬁts (277). The DASH diet
emphasizes fruits, vegetables, whole grains, low-fat
dairy products, and discourages sugar-sweetened
foods and beverages, red meat, and added fats (254).
The DASH diet was associated with lower systolic
blood pressure, diastolic blood pressure, and choles-
terol. However, the DASH trials were short and not
designed to evaluate the impact of this diet on CVD
clinical events. Further improvements in cardio-
vascular risk factors were seen when part of the
carbohydrate in DASH was replaced with either
monounsaturated fat or protein (278). In prospective
cohort studies, a higher adherence to a DASH dietary
pattern is associated with reduced stroke, as well as
all-cause, CVD, and cancer mortality (279,280). The
Portfolio Diet (281), which includes 30 g/day of nuts,
20 g/day of viscous ﬁber (i.e., oats, barley, legumes),
80 g/day of vegetable protein (soy, beans, chickpeas,
lentils), and 2 g/day of plant sterols (plant sterol
margarine) from plant foods, lowers LDL-C by up to
30% within 4 weeks, similar to statins (281). Re-
ductions of 13% to 23% are maintained when this diet
was extended to 12 months (282,283). However, no
RCT has evaluated the impact of this diet on CVD
clinical events. Strong evidence from prospectivecohort studies and randomized trials shows reduced
CHD with the consumption of a higher-fat Mediterra-
nean diet (196). In the PREDIMED randomized trial a
plant-based diet high in nuts or extra virgin olive oil,
vegetables, fruits, legumes, ﬁsh, and poultry but low
in red meats, sweets, and whole-fat dairy was superior
to the control group assigned to a low-fat Western diet
in preventing CVD (164). It bears mention that low-fat
diets have not been particularly effective for long-
term CVD risk reduction, partly due to the difﬁculty
sustaining such a diet in the long term (284,285).
Online Table 1 translates the essence of the Mediter-
ranean diet to other regions and cultures, suggesting
replacement foods that maintain the major food
groups in particular regions. Randomized trials of CVD
outcomes are needed in different regions of the world.
The Central Illustration provides a summary of the
key diet changes needed and some of the options for
changing our food system to attain this goal is sum-
marized in the next section.
HEALTHIER FOOD SYSTEMS
If more people made healthier choices, the food sys-
tems would have greater incentives to produce
healthier items. At the same time, a healthier food
supply enables individuals to make healthier choices.
Developing food systems that underpin healthier di-
etary patterns on the basis of our consensus noted
previously involves improving the food supply by
producing more heart-healthy foods and fewer foods
associated with CVD (Central Illustration). It extends
beyond merely growing and raising these foods to
ensuring they reach people everywhere in a still
healthy form in a way that is accessible and accept-
able, including groups of lower socioeconomic status.
Changing food systems thus extends beyond agricul-
tural production to what happens between farm and
fork (31). This is challenging in the modern global food
system given the often extensive distance between
production and consumption; multiple and complex
transformations in ingredients and foods between
farm and fork; and a multitude of other forces
discouraging diversity and freshness. Producing more
poultry, for example, may be seen as a way to enhance
the quality of the food supply because it is healthier
relative to red meat, but much chicken is transformed
into fast food and other calorie-rich, ultra-processed,
heavily advertised presentations (286). Additional
public health impacts of industrial poultry production
are also well reported, such as food-borne disease
(e.g., E. coli, Salmonella, Listeria), antimicrobial resi-
dues, and avian ﬂu (287). Clearly families and in-
dividuals also play a major role in selecting the quality
CENTRAL ILLUSTRATION Diet, Cardiovascular Disease, and the Food System: Recommendations for Global Food System Changes
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This ﬁgure summarizes the relationship between the major components of diet as well as overall dietary patterns that will lead to reduced risk of cardiovascular disease.
This summarizes how the global food system contributes to dietary patterns that greatly increase the risks for the population to experience ill health. Although many
perceive food consumption as an individual choice driven by the desires of consumers for tasty food, linked with rising incomes and urbanization, we have shown
that the food system and all the stakeholders within it should play a major role. DASH ¼ Dietary Approaches to Stop Hypertension; MUFA ¼ mono-unsaturated fats;
NCD ¼ noncommunicable disease; PUFA ¼ polyunsaturated fats; SSB ¼ sugar-sweetened beverage.
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1605of their diet, particularly in HIC and among middle-
and higher-income LMIC, but our focus herein is on
the broader environmental factors affecting this
system.
There are also huge political, economic, and envi-
ronmental challenges to changing the food system,
not the least of which is the capacity of governments
to implement change (288). Yet change is possible. It
can start with a wider understanding of how the
modern food system shapes dietary patterns and
eating behaviors, as supported by education that
makes clear the interrelationship between food sys-
tems, food environments, diets and adverse public
health and environmental outcomes, and the poten-
tial for better diets to lead to major improvements inpublic health and environmental sustainability. The
pace and effectiveness of improvements will largely
depend on political will, encouraged and reinforced
by the work of civil society, with health-related pro-
fessionals having important contributions to make
and dietary guidelines sensitive to these issues hav-
ing a major role to play.
IDENTIFYING FOOD SYSTEM SOLUTIONS. The task
may be daunting, but there are many ways to move
toward healthier food systems. There is no one solu-
tion but a multitude of both top-down and bottom-up
starting points. Many changes need not be drastic
and costly, and small modiﬁcations can improve
nutritional intakes and overall diet quality (Online
Appendix).
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1606The ﬁrst “top-down” step is to undertake rigorous
analytical work at the global level in order to identify
the main levers for change for each of the food groups
and provide a framework more conducive to the
success of bottom-up approaches (289). The bottom-
up approach starts with engaging communities in
ﬁnding their own solutions to food system–related
problems with an emphasis on overall dietary pat-
terns (277,290–292).
Experience indicates actions by the following key
actors have potential to improve food systems, many
of which can simultaneously have health and envi-
ronmental beneﬁts:
 Governments can review policies in various sectors
which inﬂuence food systems for coherence with
dietary objectives and realign policies so they “do
no harm” (293–296); explore ﬁscal incentives from
farm to fork to realign food and agricultural sys-
tems; and set a coherent framework of standards
and regulations for large transnational food com-
panies to disincentivize the production, sale, and
marketing of foods high in reﬁned carbohydrates
and low in heart-healthy elements, including clear
standards for promotional marketing (297,298).
Continued efforts are needed to develop a systems-
oriented, mutually reinforcing approach to reduce
excessive consumption of SSBs (299).
 Communities can identify community-based solu-
tions to poor food access, such as through engaging
local/small/family farmers and/or innovative
community-oriented production and marketing of
whole grains, fruits, vegetables, legumes, and nuts
in low-income communities, and developing local
food policy councils (300).
 Farmers and food producers can leverage the
potential of traditional/indigenous crops as part
of biodiverse food systems, and support urban
food production. Low-input, biodiverse farming
systems are more sustainable than high-input
monocultures and tend to be more productive
per land area, making greater use of ecological
space.
 Agricultural and rural development agencies and
programs can, where whole grains, fruits, vegeta-
bles, legumes, and nuts are in short supply in
LMIC, invest in transportation, distribution net-
works, procurement logistics, and price informa-
tion systems to remove supply bottlenecks.
 Investors in agriculture and food research and
development can shift investments and research
toward the production, distribution, and con-
sumption of healthier, more diverse sources of
nutrients and agricultural programs; make nationaland international investments in food research
aligned with a healthy food supply; and invest in
pre- and post-harvest systems to reduce food waste
and focusing on recycling in home food waste
(101,301).
 Food processors and manufacturers of all scales
can ensure food processing does not strip ﬁber and
positive nutrients from foods; direct research and
marketing to enhance the desirability of nutritious
foods to consumers.
 Educational institutions can improve curricula and
build capacity among nutrition and public health
students and professionals to identify and imple-
ment multisectorial food systems solutions to un-
healthy diets.
In addition, middle-income countries and HIC
have introduced measures to improve food environ-
ments—mainly introduced in the context of obesity—
including (302):
 Taxation of SSBs and unessential foods (junk foods
in general) in Mexico. A number of other LMIC are
considering these taxes, and several European
countries have introduced taxes on different food
groups.
 Front-of-pack labels on packaged food products
considered healthy (303) or unhealthy (304).
Several Latin American countries have regulated
front-of-pack labels, including Ecuador’s trafﬁc
light label (implemented in 2014), and Chile’s
warning label (being implemented over the next 4
years). Several Asian countries are developing a
healthier choices option.
 Mandatory school food standards are the most
widely implemented action, in around 11 middle-
income countries and 15 HIC. However the direc-
tion of the mandate must be appropriate.
 Effective marketing controls of unhealthy foods
and beverages have not been widely implemented.
Chile’s new program is the most extensive
(implemented over the 2015 to 2019 period).
Mexico, South Korea, the United Kingdom, and
Ireland present rare exceptions, but the regulations
have loopholes and do not comprehensively
restrict marketing. Efforts to restrict marketing in
other countries through regulation have been met
with strong opposition from the food and adver-
tising industries. A critical issue is to go beyond
marketing focused at children’s TV to all TV
viewed during key hours or full time and also to
consider all other media. A second issue is linking
marketing controls with the front-of-pack labeling
efforts so either only healthy foods are marketed or
all unhealthy foods are not allowed to be marketed.
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1607 Encouraging food processers to produce vegetable
protein–rich foods as meat and dairy alternatives
with subsidies/tax incentives.
Although the evidence base for these policy op-
tions is growing more and more rigorous, evaluation
of these actions is needed, though econometric
evaluations of the Mexican 10% SSB tax and 8%
junk food taxes are underway using longitudinal
nationally representative scanned food purchase
data at the household level. A critical need is much
more evaluation of all these options, including to
assessments of how they feed back to affect the
food system (302,305). Nutrition labels, for example,
have been shown to have a clear impact on refor-
mulation (303,306).
CONCLUSIONS
This paper has provided a state-of-the-art review of
the link between speciﬁc macronutrients and foods
and CVD and summarized how the global food system
contributes to dietary patterns that greatly increase
the risks for the population to experience ill health.
Although many perceive food consumption as an in-
dividual choice driven by the desires of consu-
mers for tasty food, linked with rising incomes and
urbanization, we have shown that the food system
and all the stakeholders within it should play a major
role (307).
Short-term controlled-feeding studies with CVD
risk factors as outcomes; long-term prospective
cohort studies with CHD, stroke, and T2DM as out-
comes; and a limited number of RCTs with CVD as the
outcome collectively show that multiple aspects
of diet substantially inﬂuence CVD risk. However,
similar data are needed from LMIC as dietary patterns
differ in various regions of the world and the context
in which foods are accessed differs markedly.
On the basis of the current evidence, the optimal
dietary pattern to reduce CVD is one that emphasizes
whole grains, fruits and vegetables, legumes, nuts,
ﬁsh, poultry, and moderate dairy and heart-healthy
vegetable oil intake; this pattern will likely reduce
the CVD risk by about one-third. This healthy dietary
pattern needs also to be low in reﬁned grains, added
sugars, trans fats, SSBs, and red and processed meats.
The traditional Mediterranean-type diet provides a
well-tested prototype for this healthy dietary pattern.
Given that we now understand the components of
this diet sufﬁciently, it may be possible to translate
this pattern to other regions, with appropriate similar
food replacements on the basis of food availability
and preferences (Online Table 1). Despite signiﬁcant
advances in our understanding of optimal dietarypatterns to prevent CVD, additional research
including large cohort studies and RCTs of dietary
patterns are needed in different regions of the world
to address existing knowledge gaps. This includes
evaluation of the impact of speciﬁc fruits and vege-
tables, types of dairy foods, type and amount of car-
bohydrate, optimal cooking oils, region-speciﬁc
dietary patterns, and cooking methods. Finally, we
acknowledge that although this paper is focused on
CVD, dietary choices and recommendations should
also be made with consideration of the environmental
implications of food choice (i.e., the environmental
impact of poultry, livestock/cattle production, and
diminishing wild ﬁsh stocks) and the role of diet in
other disease processes. Human health must be
linked to environmental health—the basis of the new
Sustainable Development Goals (241). Additionally,
modiﬁcations to our recommendations may provide
improved protection against cancer or neurodegen-
erative or autoimmune diseases.
Policy actions and interventions that improve food
supplies and dietary patterns have social, cultural,
and environmental beneﬁts. There are many oppor-
tunities to increase access to healthy food that are
also likely to have signiﬁcant environmental beneﬁts.
Health providers throughout the world can lead by
advocating for action in the food system, as well as in
food environments and behavior change communi-
cation. So too can other professionals, civil society
and public interest organizations, inﬂuential writers
and journalists, and organizations of chefs and gas-
tronomes. A synergistic systems approach is essen-
tial. The challenge to create and sustain what is
healthy and change what is unhealthy is compelling
because improving the nourishment that goes into
our bodies can have wide-ranging beneﬁts in im-
proving the health of societies and environments. A
second major challenge is to identify and implement
effective food systems and solutions and evaluate the
national and local level policy actions underway to
improve our diets.
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